Skip to content
Viking Therapeutics, Inc.
$24,000,000
IPO
Represented Laidlaw & Co. (UK) & Feltl and Co. as Underwriters
Common Stock & Warrants
May 2015
Read More
Professional Diversity Network
$5,000,000
Public Offering
Pursuant to S-3 Shelf Registration
Represent Aegis Capital as Undewriter
April 2015
Read More
Solar3D
$12,500,000
Public Offering & NASDAQ Uplisting
Offering underwritten by Cowen & Company LLC
Common Stock & Warrants
February 2015
Read More
CollabRX, Inc.
$3,000,000
Public Offering Pursuant to S-3 Registration
Common Stock
February 2015
Read More
CollabRX, Inc.
$5,520,000
Represented Aegis Capital Corp. as Sole Book-Running Manager
Public Offering
Common Stock & Warrants
February 2015
Read More
Actinium Pharmaceuticals Inc.
$20,000,000
Represented Laidlaw & Company (UK) Ltd.
Public Offering
Common Stock & Warrants
February 2015
Read More
Trovagene, Inc.
$23,000,000
Public Offering
Common Stock
February 2015
Read More
Tonix Pharmaceuticals Holding Corp.
$28,700,000
Public Offering
Common Stock
February 2015
Read More
PlasmaTech Biopharmaceuticals, Inc.
$14,000,000
Represented H.C. Wainwright & Co. and Aegis Capital Corp as Underwriters
Common Stock and Warrants
December 2014
Read More
Can-Fite Biopharma Ltd.
$8,000,000
At-the-Market Registered Direct Offering
December 2014
Read More
